New Journey Health Technology Group Co., Ltd. (002219.SZ) has announced the signing of a framework agreement with its controlling shareholder, New Journey Group, for the indirect acquisition of a 65% equity interest in Taiyuan Huaejian Hospital Co., Ltd. The transaction will be structured through a special purpose vehicle (SPV) established by New Journey Group and/or its affiliates. The SPV will first acquire the 65% stake in Huaejian Hospital from Beijing Hongci Medical Investment Management Co., Ltd. Subsequently, New Journey Health Technology and/or its subsidiaries will purchase 100% of the SPV, thereby indirectly obtaining the 65% ownership in the hospital.
Established in 1956, Huaejian Hospital is a Grade II, Level A general hospital with 400 approved beds. It operates 31 clinical departments and 8 medical technology departments, featuring seven municipal-level key specialties in Taiyuan, including medical imaging, pharmacy, general surgery, neurology, ultrasound medicine, obstetrics, and pediatrics, along with eight renowned physician studios. The hospital functions as a regional medical institution integrating prevention, healthcare, education, and research.
Huaejian Hospital has received approval from the Taiyuan Municipal Health Commission to transition to a for-profit entity. Its application for deregistration as an institutional legal entity has been submitted to the Taiyuan Municipal Commission Office for Public Sector Reform and is under review. Upon approval, the hospital must complete tax clearance and deregistration procedures with the Taiyuan Municipal Administration for Market Regulation. Following these steps, Huaejian Hospital Co., Ltd. will assume all assets, personnel, qualifications, debts, and other obligations of the original hospital and commence operations as a for-profit medical institution.
Comments